MCFARLANE NEIL F. (President and CEO) sold 4.6% of their position (20K shares) of ZEVRA THERAPEUTICS, INC. on the open market
Open‑market sale worth $224.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/13/2026ACC: 0001434647-26-000075
DirectorOfficer· President and CEO
Since Feb 2026
-20K
Net shares
Net seller
$224.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
50K acquired · 70K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+50K
Price / share
—
Trade value
—
% of position
12.9%
10/10/2026
387.23K→437.23K
Common Stock
Direct
Shares
−20K
Price / share
$11.25
Trade value
$224.95K
% of position
4.6%
10/12/2026
437.23K→417.23K
Total
Net shares
+30K
Net value
-$224.95K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/10/2026 | M · Option Exercise | +50K | — | — | 12.9% | 387.23K | 437.23K |
| Common Stock Direct | 10/12/2026 | S · Sale | −20K | $11.25 | $224.95K | 4.6% | 437.23K | 417.23K |
| Total | +30K | -$224.95K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
50K shares
Shares
−50K
Strike price
0
Held after
50K
Exercisable
—
10/10/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock50K shares | 10/10/2026 | M · Option Exercise | −50K | 0 | — | 50K |